Showing results (191-200 of 259) with videos related to

Sort By:
Pageof 26
Pharmacopsychiatry|June 10, 2026
Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and NabiloneFriederike Amann, Gudrun Hefner, Peter Cremer-Schaeffer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2003
How does the benzamide antipsychotic amisulpride get into the brain?--An in vitro approach comparing amisulpride with clozapineSebastian Härtter, Sabine Hüwel, Tina Lohmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 11, 2020
Prevalence and sort of pharmacokinetic drug-drug interactions in hospitalized psychiatric patientsGudrun Hefner, Jan Wolff, Martina Hahn, et al.
Neuropharmacology|August 2, 2011
Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major DepressionNadine Dreimüller, Konrad Friedrich Schlicht, Stefanie Wagner, et al.
The Journal of Clinical Psychiatry|May 21, 2020
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und PharmakopsychiatrieGeorgios Schoretsanitis, John M Kane, Christoph U Correll, et al.
Clinical Pharmacokinetics|June 18, 2021
Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug ReactionsGeorgios Schoretsanitis, Ekkehard Haen, Daria Piacentino, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 28, 2009
Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter geneIon Anghelescu, Christoph Klawe, Peter Singer, et al.
Fortschritte Der Neurologie-Psychiatrie|May 26, 2019
[Different number of contraindications between summaries of product characteristics (SmPC) of drugs with the same active ingredients - an analysis of data from SmPCs of neuropsychiatric drugs]Maximilian Gahr, Roland W Freudenmann, Bernhard J Connemann, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 24, 2020
[Use of summaries of product characteristics (SmPC) among family doctors and pharmacists in the context of the aut-idem regulation: Results of an exploratory cross-sectional survey]Maximilian Gahr, Roland W Freudenmann, Bernhard J Connemann, et al.
Pharmacopsychiatry|April 17, 2025
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson's Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysisNazar Kuzo, Marianna Piras, Ulrich C Lutz, et al.
Pageof 26